International Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025

The 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop is an advanced two-day educational event dedicated to the latest innovations in immune-based treatments for multiple myeloma. This workshop delivers in-depth scientific updates alongside practical, case-driven discussions to help participants optimize clinical outcomes.
What You Will Learn

Latest clinical trial data on CAR T-cell therapies targeting BCMA and GPRC5D

Advances in bispecific antibodies and T-cell engagers, including teclistamab, elranatamab, talquetamab, and others

Strategies to manage toxicities such as cytokine release syndrome, cytopenias, and organ-specific complications

Emerging therapies: allogeneic CAR T, CAR-NK cells, dual antigen targeting, and trispecific antibodies

Approaches to overcome resistance and enhance treatment response through combination regimens and immune modulation

Event Details

Dates: March 28–29, 2025

Location: Boston Marriott Long Wharf, Boston, Massachusetts

Who Should AttendThis workshop is ideal for:

Hematologists and oncologists treating multiple myeloma

Clinical researchers and trial investigators in immune therapy

Advanced practice providers and pharmacists involved in immune effector cell therapy care

Industry professionals and academic experts interested in translating research into clinical practice

Why Attend

Gain comprehensive insights into the latest immune effector cell therapy developments

Learn practical management strategies for complex therapy-related toxicities

Network with global leaders and peers in the myeloma research community

Apply cutting-edge scientific knowledge directly to patient care

 
+ Topics:
IEC2025Program.pdf
SESSION 1 CLINICAL UPDATES ON CAR T CELLS.mp4
SESSION 2 CLINICAL UPDATES ON BISPECIFIC ABS TCE’S.mp4
SESSION 3 PRACTICAL CONSIDERATIONS FOR IMMUNE THERAPY.mp4
SESSION 4 NOVEL APPROACHES IN THE CLINIC.mp4
SESSION 5 MANAGING TOXICITIES OF T CELL ENGAGING THERAPIES.mp4
SESSION 6 CORRELATES OF RESPONSE AND RESISTANCE.mp4
SESSION 7 STRATEGIES TO IMPROVE IMMUNE EFFECTOR CELL THERAPIES.mp4
SESSION 8 KEY QUESTIONS IN IMMUNE THERAPY.mp4
WORKSHOP ON SECONDARY MALIGNANCIES AND NON-RELAPSE MORTALITY.mp4